What is Articular Engineering?
Articular Engineering, LLC, established in 1999 and headquartered in Illinois, is a pioneering biotech firm dedicated to advancing treatment options for articular cartilage and intervertebral disc disorders. The company has built a robust intellectual property portfolio through its focus on cell-based and tissue-modifying technologies. Articular Engineering serves a global clientele within the research, pharmaceutical, and biotech industries by providing highly customizable orthopedic tissues and cell cultures, tailored to meet precise research protocols.
How much funding has Articular Engineering raised?
Articular Engineering has raised a total of $23K across 1 funding round:
Debt
$23K
Debt (2021): $23K with participation from PPP
Key Investors in Articular Engineering
PPP
Public-Private Partnership
What's next for Articular Engineering?
With the recent influx of expansion capital, Articular Engineering is poised for significant growth. The substantial funding at this Series B/C stage suggests a strategic push towards scaling operations, potentially expanding research and development efforts, and broadening market penetration. This investment will likely accelerate the commercialization of their patented technologies and further solidify their position as a key supplier of specialized orthopedic tissues and cell cultures to the global scientific community.
See full Articular Engineering company page
